Back to companies

Annexon Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Annexon Inc (Annexon) is a biopharmaceutical company that develops innovative therapies for the treatment of autoimmune, neurodegenerative and ophthalmic disorders. The company pipeline products including ANX005 (tanruprubart) for guillain-barre syndrome; ANX007 (vonaprument) which treats geographic atrophy; ANX1502 for the treatment of Autoimmune Indications; ANX005 targets huntington’s disease and amyotrophic lateral sclerosis; and ANX009 treats lupus nephritis. It leverages proprietary C1q technology platform, is the initiating molecule of the classical complement pathway that prevents downstream activation of all tissue-damaging components. Annexon is headquartered in Brisbane, California, the US.

 Gain a 360-degree view of Annexon Inc and make more informed decisions for your business Gain a 360-degree view of Annexon Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address Building C, 2nd Floor, 1400 Sierra Point Parkway, Brisbane, California, 94005
Website annexonbio.com
Telephone 1 650 8225500
No of Employees 99
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange ANNX (NASD)
EPS XYZ
Net Income (2024) XYZ -3% (2024 vs 2023)
Market Cap* $997.2M
   
   
* As of and is in US$
View Annexon Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products
Pipeline
ANX005 (tanruprubart): Guillain-Barre Syndrome (GBS)
ANX007 (vonaprument): Geographic Atrophy (GA)
XYZ
XYZ
XYZ
Understand Annexon Inc portfolio and identify potential areas for collaboration Understand Annexon Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Annexon Inc Moderna Inc Alector Inc Cognition Therapeutics Inc
Headquarters United States of America United States of America United States of America United States of America
City Brisbane Cambridge South San Francisco Purchase
State/Province California Massachusetts California New York
No. of Employees 99 5,800 156 25
Entity Type Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Douglas E Love Chief Executive Officer; Director; President Executive Board 2014 57
Jennifer Lew Chief Financial Officer; Executive Vice President Senior Management 2019 52
Jamie Dananberg, M.D. Executive Vice President; Chief Medical Officer Senior Management 2023 67
Rick Artis, Ph.D. Chief Scientific Officer; Executive Vice President Senior Management 2023 65
Ted Yednock, Ph.D. Executive Vice President; Chief Innovation Officer Senior Management 2013 67
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Annexon Inc key executives to enhance your sales strategy Gain insight into Annexon Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?